Novartis today announced the US Food and Drug Administration (FDA) has granted accelerated approval for Kymriah ® (tisagenlecleucel) for the treatment of adult patients with relapsed or refractory ...
If you have ever perused the supplement aisle in your pharmacy, you’ve come across quite the display of vitamins and minerals. And even though you feel OK, you’ve probably wondered if you need ...
Positive initial data demonstrated pharmacologically relevant exposures Management and key opinion leaders to present complete results and provide update on expanded development of zotatifin in invest ...